Collection's Items (Sorted by Submit Date in Descending order): 21 to 40 of 1011
| Issue Date | Title | Author(s) |
| 2025 | Prevention of fatty acid-induced maladaptation in secretin tumor cell-1 enteroendocrine cells by allicin, a transient receptor potential ankyrin 1 agonist | Khare, Pragyanshu |
| 2025-09 | Characterization and evaluation of varieties of microcrystalline cellulose in formulations containing lactose incompatible drugs: Influence on compactibility and drug release | Pandey, Murali Monohar |
| 2025-09 | Management and prevention of neurodegenerative disorders: can antioxidant-rich dietary interventions help? | Pandey, Murali Monohar |
| 2025-11 | Recent advancements in parallel and tandem reaction-based fluorogenic probes for tracing enzymatic activities | Sidhu, Jagpreet Singh |
| 2025-03 | Esculetin and phloretin combination mitigates acute kidney injury-diabetes comorbidity via regulating mitophagy and inflammation: a dual-pronged approach | Jadhav, Hemant R.; Gaikwad, Anil Bhanudas |
| 2025-10 | Corrigendum to: Design and development of chromene-3-carboxylate derivatives as antidiabetic agents: Exploring the antidiabetic potential via dual inhibition of angiotensin II type 1 receptor and neprilysin enzyme | Gaikwad, Anil Bhanudas; Jadhav, Hemant R. |
| 2025-09 | A novel combination of exogenous klotho combined with telmisartan ameliorated diabetic cardiomyopathy via an antifibrotic mechanism | Jadhav, Hemant R.; Gaikwad, Anil Bhanudas |
| 2025 | Emerging in diabetic cardiomyopathy: molecular pathways and targets for therapeutic intervention | Jadhav, Hemant R. |
| 2025-05 | Can breakthroughs in dermal and transdermal macromolecule delivery surmount existing barriers and revolutionize future therapeutics? | Mittal, Anupama; Chitkara, Deepak |
| 2025-05 | Autophagy as a potential therapeutic target in regulating improper cellular proliferation | Chitkara, Deepak |
| 2025-09 | Simultaneous estimation of rapamycin, temozolomide and its metabolites using UPLC-ESI-MS/MS and its application to pharmacokinetics in C6-glioma bearing animals | Mittal, Anupama; Chitkara, Deepak |
| 2025-10 | cRGD-functionalized nanohybrid conjugates codelivering temozolomide and rapamycin for treating Glioblastoma multiforme: in vitro and in vivo evaluation | Mittal, Anupama; Chitkara, Deepak |
| 2025-10 | Lipopolymeric nanoplex-mediated CRISPR/Cas9 delivery for VEGF-A knockdown in psoriatic angiogenesis | Yadav, Sushil; Mittal, Anupama; Chitkara, Deepak |
| 2024-01 | Plant essential oils as potent antimicrobials | Paul, Atish Tulshiram |
| 2024-01 | Discovery of novel chromone and acrylate-based pancreatic lipase inhibitors: Molecular modelling, synthesis, and in vitro evaluation for the treatment of obesity | Paul, Atish Tulshiram |
| 2024-12 | Computational insights into human UCP1 activators through molecular docking, MM-GBSA, and molecular dynamics simulation studies | Paul, Atish Tulshiram |
| 2025-09 | Synthetic pancreatic lipase inhibitors in obesity treatment: current updates on in silico design, synthesis, bioactivity, and SAR | Paul, Atish Tulshiram |
| 2025-05 | Quantitative UV spectrophotometric analysis of teriflunomide and quercetin in dual drug-loaded transferosomes using the absorption factor method | Jindal, Anil B.; Paul, Atish Tulshiram |
| 2025-08 | Histone demethylase inhibitors: developmental insights and current status | Paul, Atish Tulshiram; Jadhav, Hemant R. |
| 2025-12 | Unveiling the potential of naturally occurring rosmarinic acid inspired analogues as pancreatic lipase inhibitors: In silico, in vitro and in vivo evaluation as anti-obesity agents | Paul, Atish Tulshiram |
Collection's Items (Sorted by Submit Date in Descending order): 21 to 40 of 1011
